ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tardive Dyskinesia Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-38S5955
Home | Market Reports | Health| Mental Health
Global Tardive Dyskinesia Market Insights Forecast to 2028
BUY CHAPTERS

Global Tardive Dyskinesia Market Research Report 2025

Code: QYRE-Auto-38S5955
Report
September 2025
Pages:63
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bausch Health
Neurocrine Biosciences
Teva Pharmaceuticals Industries

Tardive Dyskinesia Market

The global market for Tardive Dyskinesia was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Tardive Dyskinesia (TD) market is estimated to post significant growth in coming years, owing to rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription and increasing incidence of neurological disorders.
The key factors driving the growth of the Tardive dyskinesia market are rising schizophrenia patients, increasing bipolar patients, growing antipsychotic prescription, increased use of long-term neuroleptic drugs and increasing incidence of neurological disorders. However, the expansion of the market is hindered by side effects of drugs and under-diagnosed.
This report aims to provide a comprehensive presentation of the global market for Tardive Dyskinesia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tardive Dyskinesia.
The Tardive Dyskinesia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tardive Dyskinesia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tardive Dyskinesia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tardive Dyskinesia Market Report

Report Metric Details
Report Name Tardive Dyskinesia Market
Segment by Type
  • Dopamine-Depleting Medications
  • GABA Receptor Agonist Medications
  • Anticholinergic Medications
Segment by Application
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bausch Health, Neurocrine Biosciences, Teva Pharmaceuticals Industries
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tardive Dyskinesia company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tardive Dyskinesia Market report?

Ans: The main players in the Tardive Dyskinesia Market are Bausch Health, Neurocrine Biosciences, Teva Pharmaceuticals Industries

What are the Application segmentation covered in the Tardive Dyskinesia Market report?

Ans: The Applications covered in the Tardive Dyskinesia Market report are Hospitals, Ambulatory Surgical Centers, Diagnostic Centers

What are the Type segmentation covered in the Tardive Dyskinesia Market report?

Ans: The Types covered in the Tardive Dyskinesia Market report are Dopamine-Depleting Medications, GABA Receptor Agonist Medications, Anticholinergic Medications

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tardive Dyskinesia Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Dopamine-Depleting Medications
1.2.3 GABA Receptor Agonist Medications
1.2.4 Anticholinergic Medications
1.3 Market by Application
1.3.1 Global Tardive Dyskinesia Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tardive Dyskinesia Market Perspective (2020-2031)
2.2 Global Tardive Dyskinesia Growth Trends by Region
2.2.1 Global Tardive Dyskinesia Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tardive Dyskinesia Historic Market Size by Region (2020-2025)
2.2.3 Tardive Dyskinesia Forecasted Market Size by Region (2026-2031)
2.3 Tardive Dyskinesia Market Dynamics
2.3.1 Tardive Dyskinesia Industry Trends
2.3.2 Tardive Dyskinesia Market Drivers
2.3.3 Tardive Dyskinesia Market Challenges
2.3.4 Tardive Dyskinesia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tardive Dyskinesia Players by Revenue
3.1.1 Global Top Tardive Dyskinesia Players by Revenue (2020-2025)
3.1.2 Global Tardive Dyskinesia Revenue Market Share by Players (2020-2025)
3.2 Global Tardive Dyskinesia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tardive Dyskinesia Revenue
3.4 Global Tardive Dyskinesia Market Concentration Ratio
3.4.1 Global Tardive Dyskinesia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia Revenue in 2024
3.5 Global Key Players of Tardive Dyskinesia Head office and Area Served
3.6 Global Key Players of Tardive Dyskinesia, Product and Application
3.7 Global Key Players of Tardive Dyskinesia, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tardive Dyskinesia Breakdown Data by Type
4.1 Global Tardive Dyskinesia Historic Market Size by Type (2020-2025)
4.2 Global Tardive Dyskinesia Forecasted Market Size by Type (2026-2031)
5 Tardive Dyskinesia Breakdown Data by Application
5.1 Global Tardive Dyskinesia Historic Market Size by Application (2020-2025)
5.2 Global Tardive Dyskinesia Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tardive Dyskinesia Market Size (2020-2031)
6.2 North America Tardive Dyskinesia Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tardive Dyskinesia Market Size by Country (2020-2025)
6.4 North America Tardive Dyskinesia Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tardive Dyskinesia Market Size (2020-2031)
7.2 Europe Tardive Dyskinesia Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tardive Dyskinesia Market Size by Country (2020-2025)
7.4 Europe Tardive Dyskinesia Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tardive Dyskinesia Market Size (2020-2031)
8.2 Asia-Pacific Tardive Dyskinesia Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tardive Dyskinesia Market Size by Region (2020-2025)
8.4 Asia-Pacific Tardive Dyskinesia Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tardive Dyskinesia Market Size (2020-2031)
9.2 Latin America Tardive Dyskinesia Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tardive Dyskinesia Market Size by Country (2020-2025)
9.4 Latin America Tardive Dyskinesia Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tardive Dyskinesia Market Size (2020-2031)
10.2 Middle East & Africa Tardive Dyskinesia Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tardive Dyskinesia Market Size by Country (2020-2025)
10.4 Middle East & Africa Tardive Dyskinesia Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Tardive Dyskinesia Introduction
11.1.4 Bausch Health Revenue in Tardive Dyskinesia Business (2020-2025)
11.1.5 Bausch Health Recent Development
11.2 Neurocrine Biosciences
11.2.1 Neurocrine Biosciences Company Details
11.2.2 Neurocrine Biosciences Business Overview
11.2.3 Neurocrine Biosciences Tardive Dyskinesia Introduction
11.2.4 Neurocrine Biosciences Revenue in Tardive Dyskinesia Business (2020-2025)
11.2.5 Neurocrine Biosciences Recent Development
11.3 Teva Pharmaceuticals Industries
11.3.1 Teva Pharmaceuticals Industries Company Details
11.3.2 Teva Pharmaceuticals Industries Business Overview
11.3.3 Teva Pharmaceuticals Industries Tardive Dyskinesia Introduction
11.3.4 Teva Pharmaceuticals Industries Revenue in Tardive Dyskinesia Business (2020-2025)
11.3.5 Teva Pharmaceuticals Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bausch Health
Neurocrine Biosciences
Teva Pharmaceuticals Industries
List of Tables
 Table 1. Global Tardive Dyskinesia Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Dopamine-Depleting Medications
 Table 3. Key Players of GABA Receptor Agonist Medications
 Table 4. Key Players of Anticholinergic Medications
 Table 5. Global Tardive Dyskinesia Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Tardive Dyskinesia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Tardive Dyskinesia Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Tardive Dyskinesia Market Share by Region (2020-2025)
 Table 9. Global Tardive Dyskinesia Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Tardive Dyskinesia Market Share by Region (2026-2031)
 Table 11. Tardive Dyskinesia Market Trends
 Table 12. Tardive Dyskinesia Market Drivers
 Table 13. Tardive Dyskinesia Market Challenges
 Table 14. Tardive Dyskinesia Market Restraints
 Table 15. Global Tardive Dyskinesia Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Tardive Dyskinesia Market Share by Players (2020-2025)
 Table 17. Global Top Tardive Dyskinesia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia as of 2024)
 Table 18. Ranking of Global Top Tardive Dyskinesia Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Tardive Dyskinesia Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Tardive Dyskinesia, Headquarters and Area Served
 Table 21. Global Key Players of Tardive Dyskinesia, Product and Application
 Table 22. Global Key Players of Tardive Dyskinesia, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Tardive Dyskinesia Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Tardive Dyskinesia Revenue Market Share by Type (2020-2025)
 Table 26. Global Tardive Dyskinesia Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Tardive Dyskinesia Revenue Market Share by Type (2026-2031)
 Table 28. Global Tardive Dyskinesia Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Tardive Dyskinesia Revenue Market Share by Application (2020-2025)
 Table 30. Global Tardive Dyskinesia Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Tardive Dyskinesia Revenue Market Share by Application (2026-2031)
 Table 32. North America Tardive Dyskinesia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Tardive Dyskinesia Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Tardive Dyskinesia Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Tardive Dyskinesia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Tardive Dyskinesia Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Tardive Dyskinesia Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Tardive Dyskinesia Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Tardive Dyskinesia Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Tardive Dyskinesia Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Tardive Dyskinesia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Tardive Dyskinesia Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Tardive Dyskinesia Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Tardive Dyskinesia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Tardive Dyskinesia Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Tardive Dyskinesia Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Bausch Health Company Details
 Table 48. Bausch Health Business Overview
 Table 49. Bausch Health Tardive Dyskinesia Product
 Table 50. Bausch Health Revenue in Tardive Dyskinesia Business (2020-2025) & (US$ Million)
 Table 51. Bausch Health Recent Development
 Table 52. Neurocrine Biosciences Company Details
 Table 53. Neurocrine Biosciences Business Overview
 Table 54. Neurocrine Biosciences Tardive Dyskinesia Product
 Table 55. Neurocrine Biosciences Revenue in Tardive Dyskinesia Business (2020-2025) & (US$ Million)
 Table 56. Neurocrine Biosciences Recent Development
 Table 57. Teva Pharmaceuticals Industries Company Details
 Table 58. Teva Pharmaceuticals Industries Business Overview
 Table 59. Teva Pharmaceuticals Industries Tardive Dyskinesia Product
 Table 60. Teva Pharmaceuticals Industries Revenue in Tardive Dyskinesia Business (2020-2025) & (US$ Million)
 Table 61. Teva Pharmaceuticals Industries Recent Development
 Table 62. Research Programs/Design for This Report
 Table 63. Key Data Information from Secondary Sources
 Table 64. Key Data Information from Primary Sources
 Table 65. Authors List of This Report


List of Figures
 Figure 1. Tardive Dyskinesia Picture
 Figure 2. Global Tardive Dyskinesia Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tardive Dyskinesia Market Share by Type: 2024 VS 2031
 Figure 4. Dopamine-Depleting Medications Features
 Figure 5. GABA Receptor Agonist Medications Features
 Figure 6. Anticholinergic Medications Features
 Figure 7. Global Tardive Dyskinesia Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Tardive Dyskinesia Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Ambulatory Surgical Centers Case Studies
 Figure 11. Diagnostic Centers Case Studies
 Figure 12. Tardive Dyskinesia Report Years Considered
 Figure 13. Global Tardive Dyskinesia Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Tardive Dyskinesia Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Tardive Dyskinesia Market Share by Region: 2024 VS 2031
 Figure 16. Global Tardive Dyskinesia Market Share by Players in 2024
 Figure 17. Global Top Tardive Dyskinesia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Tardive Dyskinesia Revenue in 2024
 Figure 19. North America Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Tardive Dyskinesia Market Share by Country (2020-2031)
 Figure 21. United States Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Tardive Dyskinesia Market Share by Country (2020-2031)
 Figure 25. Germany Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Tardive Dyskinesia Market Share by Region (2020-2031)
 Figure 33. China Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Tardive Dyskinesia Market Share by Country (2020-2031)
 Figure 41. Mexico Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Tardive Dyskinesia Market Share by Country (2020-2031)
 Figure 45. Turkey Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Tardive Dyskinesia Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Bausch Health Revenue Growth Rate in Tardive Dyskinesia Business (2020-2025)
 Figure 49. Neurocrine Biosciences Revenue Growth Rate in Tardive Dyskinesia Business (2020-2025)
 Figure 50. Teva Pharmaceuticals Industries Revenue Growth Rate in Tardive Dyskinesia Business (2020-2025)
 Figure 51. Bottom-up and Top-down Approaches for This Report
 Figure 52. Data Triangulation
 Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions